首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Archives of medical science

缩写:ARCH MED SCI

ISSN:1734-1922

e-ISSN:1896-9151

IF/分区:3.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引477
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hamid-Reza Mohammadi-Motlagh,Ali Mostafaie,Kamran Mansouri Hamid-Reza Mohammadi-Motlagh
Introduction: Alliumplants are an important part of the diet of many populations and there is a long-held belief in their health-enhancing properties such as cancer prevention. In this study, the anticancer and anti-infla...
Jacek Golański,Marta Michalska,Joanna Polowinczak-Przybyłek et al. Jacek Golański et al.
Introduction: Interactions between vascular endothelium and blood platelets play a crucial role in cardiovascular diseases. Ex vitro models which use endothelial cells and platelets were the essential tools to investigate...
Monika Joks,Krzysztof Myśliwiec,Krzysztof Lewandowski Monika Joks
Primary breast lymphoma (PBL) is a rare disease accounting for 0.4-0.5% of all breast malignancies. Diffuse large B-cell lymphoma (DLBCL) is the most common histological diagnosis. The clinical presentation of PBLs is usually no different f...
Wilbert S Aronow Wilbert S Aronow
Older women with low bone mineral density (BMD) have a higher prevalence of atherosclerotic vascular disease (coronary artery disease, ischemic stroke, or peripheral arterial disease) than older women with normal BMD. Three coronary angiogr...
Stephanie Seneff,Glyn Wainwright,Luca Mascitelli Stephanie Seneff
The metabolic syndrome (MetS) is manifested by a lipid triad which includes elevated serum triglycerides, small LDL particles, and low high-density lipoprotein (HDL) cholesterol, by central obesity (central adiposity), insulin resistance, g...
Manfredi Rizzo,Giovam Battista Rini Manfredi Rizzo
Ezetimibe is a selective cholesterol absorption inhibitor with an excellent side-effect profile, able to reduce low-density lipoprotein (LDL) cholesterol by 15-25% from baseline in monotherapy and on top of statins and fibrates. Yet, it see...